Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,281-2,292 of 4,306
Drug study icon
CompletedNCT02970305

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00034762

Risperidone Compared With Placebo for Schizophrenia

This study is completed. It is testing risperidone Compared With Placebo for Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Drug study icon
CompletedNCT00954122

SEROQUEL Extended Release (XR) for schizophrenia

This study is completed in Malaysia. It is testing SEROQUEL Extended Release (XR) for schizophrenia.

Multiple locations, including Johor Bahru
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Malaysia
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
TerminatedNCT00658645

Efficacy of Bifeprunox in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Radnevo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Bulgaria, China, Greece, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Drug study icon
CompletedNCT00770744

Efficacy of Lu 31-130 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including České Budějovice
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, Czechia, China, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03891186

Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol

This summary needs review. Please check the official study record and contact the research team for details.

In Portalegre
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Portugal
Sponsor
University Rovira i Virgili
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.